Product image of Heparina Sódica Gineladius (Heparin Sodium) supplied by GNH India

Heparina Sódica Gineladius

Active Ingredient:
Heparin Sodium
Origin:
EU

Heparina Sódica Gineladius (Heparin Sodium)

Heparina Sódica Gineladius is a pharmaceutical product that contains the active ingredient heparin sodium. The specific strength and dosage form are not disclosed in the available information, but it is supplied as a sterile preparation for parenteral use. Classified as an anticoagulant and antithrombotic, this prescription‑only medication is marketed within the European Union and is administered via intra‑arterial, intravenous, or subcutaneous routes.

Manufacturer / TM Owner

Gineladius, S.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Heparina Sódica Gineladius is indicated for several antithrombotic purposes in clinical practice. It is used to reduce the risk of clot formation in various high‑risk situations.

  • Prevention and treatment of deep vein thrombosis (DVT)
  • Prevention and treatment of pulmonary embolism (PE)
  • Prophylaxis of thromboembolic events during surgical procedures
  • Prophylaxis during periods of prolonged immobilization
  • Management of clotting disorders when rapid anticoagulation is required

Side Effects

Heparina Sódica Gineladius may cause a range of adverse reactions, some of which are more frequently observed than others.

Common

  • Minor bleeding at injection sites
  • Bruising or hematoma formation
  • Nausea or mild gastrointestinal discomfort
  • Transient elevation of liver enzymes
  • Mild thrombocytopenia

Serious

  • Major hemorrhage (intracranial, gastrointestinal)
  • Heparin‑induced thrombocytopenia (HIT)
  • Allergic reactions including anaphylaxis
  • Spinal or epidural hematoma when administered near the spine
  • Severe liver injury (rare)

Precautions & Warnings

Before initiating therapy with Heparina Sódica Gineladius, several safety considerations should be reviewed. These precautions help minimize the risk of complications.

  • Assess patient history for bleeding disorders or recent major surgery
  • Monitor platelet counts regularly to detect heparin‑induced thrombocytopenia
  • Evaluate renal and hepatic function, especially in patients with organ impairment
  • Use caution in pregnant or breastfeeding individuals; risk‑benefit assessment is required
  • Adjust dosing in elderly patients or those with low body weight
  • Ensure appropriate laboratory monitoring of coagulation parameters (e.g., aPTT)

Avoid Interactions

Heparina Sódica Gineladius can interact with other medications, potentially altering its anticoagulant effect or increasing bleeding risk.

Avoid

  • Concurrent use of other anticoagulants (warfarin, direct oral anticoagulants) without close monitoring
  • Non‑steroidal anti‑inflammatory drugs (NSAIDs) and aspirin, which may exacerbate bleeding
  • Thrombolytic agents (e.g., alteplase, streptokinase)

Use with caution

  • Antiplatelet agents (clopidogrel, ticagrelor)
  • Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic drugs
  • High‑dose corticosteroids
  • Certain antibiotics (e.g., vancomycin) that may affect platelet function

Frequently Asked Questions

Heparina Sódica Gineladius contains heparin sodium, which potentiates antithrombin III, leading to inhibition of thrombin (IIa) and factor Xa, thereby reducing clot formation.

The product can be administered intra‑arterially, intravenously, or subcutaneously, depending on the clinical indication and physician recommendation.

No, it is a prescription‑only medication (Rx) and must be prescribed by a qualified healthcare professional.

Pregnancy safety has not been definitively established; use only if the potential benefit justifies the potential risk to the fetus, after consulting a healthcare provider.

Regular monitoring of activated partial thromboplastin time (aPTT) and platelet counts is recommended to ensure therapeutic anticoagulation and to detect heparin‑induced thrombocytopenia.

Common adverse effects include minor bleeding at injection sites, bruising, mild nausea, transient liver enzyme elevation, and mild thrombocytopenia.

Signs of major hemorrhage (e.g., severe bleeding, blood in urine or stool), sudden drop in platelet count, allergic reactions such as rash or difficulty breathing, and spinal or epidural hematoma require urgent evaluation.

Yes, the medication is typically discontinued prior to invasive procedures to reduce bleeding risk; the exact timing should be determined by the surgeon and prescribing physician.

NSAIDs can increase the risk of gastrointestinal bleeding when used together with heparin; concurrent use should be avoided or closely monitored.

Patients with significant renal dysfunction may require dose adjustments and more frequent coagulation monitoring, as clearance of heparin can be affected.

HIT is an immune‑mediated reaction where antibodies form against the heparin‑platelet factor 4 complex, leading to a drop in platelet count and paradoxical clotting; it is a recognized serious risk with heparin therapy.

While heparin can be used for short‑term anticoagulation, long‑term management often involves transition to oral anticoagulants; the decision depends on the clinical scenario.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Heparin Sodium

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT